Compass Minerals in Q3 2026: A Saltier Quarter for CMP Growth, a Cleaner Outlook for Plant Nutrition

Executive snapshot

Compass Minerals Corp (CMP) rolled out its fiscal 2026 third-quarter results with a mix of modest pain and measurable progress. The company posted a net loss of $5.7 million for the quarter, narrowing from a $17.0 million loss a year earlier, while Adjusted EBITDA came in at $39.9 million, just shy of the $41.0 million print in the prior-year period. Translation: the Plant Nutrition slice is delivering improvement, but the Salt slice remains a driver of cost pressure.

On the balance sheet front, CMP trimmed leverage and lifted its year-end target for Adjusted EBITDA—a small victory that could translate into a tighter EPS trajectory if the gains in Plant Nutrition persist. The company’s debt story is moving in the right direction: total debt declined 13% year over year to $716.6 million, and net debt dropped 11% to $660.3 million as of June 30, 2026.

The quarter also included a preview of the full-year EPS consensus and revenue trajectory: management raised the midpoint of the 2026 revenue forecast via a revised guidance range for total company Adjusted EBITDA to a modified $218 million–$242 million, reflecting stronger Plant Nutrition performance and ongoing Salt mix and cost dynamics.

Two engines, one company: Plant Nutrition and Salt

The quarterly narrative splits into two operating acts. In Plant Nutrition, pricing gains and cost-control actions produced higher operating income and Adjusted EBITDA on a per-ton basis, reinforcing CMP’s belief that its improvement process is working. The company even signaled continued upside in this segment, helping to offset some Salt headwinds.

In Salt, management described meaningful pricing gains in highway channels during the quarter and flagged early signs of a constructive pricing environment in the consumer and industrial (C&I) product line. Yet the Salt segment faced higher per-unit product costs and distribution costs, which weighed on operating income and Adjusted EBITDA margins.

In short, Plant Nutrition is carrying the water while Salt, the heavier lift, is still wrestling with inflationary and logistics pressures. The result is a broader EBITDA outcome that improved versus the prior year in some metrics but remained challenged in others.

Guidance and outlook: a cautiously constructive bend

CMP raised the midpoint of its full-year 2026 guidance for total company Adjusted EBITDA, placing the revised range at approximately $218 million to $242 million. Management attributed the uplift to stronger Plant Nutrition performance and the ongoing reassessment of Salt dynamics—particularly around mix, inflation, and the pace of operational improvements.

The company highlighted the 2026 highway de-icing bid season as a constructive signal for pricing in core U.S. markets, suggesting that the pricing environment could remain supportive if demand and tender activity hold up. For investors focused on EPS and the revenue forecast, the key question is whether Plant Nutrition can translate its earnings upside into sustained per-share improvements as the year progresses and maintenance costs settle from elevated levels.

Analyst take and what this could portend for CMP and its peers

The narrative hinges on leverage and mix. CMP’s debt reduction improves financial flexibility and could support credit metrics even as the company navigates a commodity-price backdrop that’s not immune to seasonality or macro noise. The earnings surprise potential will likely hinge on how quickly Salt costs normalize and whether Plant Nutrition can keep delivering above-plan EBITDA and margin progression. Investors will be listening for any hint of sustained price realization in Salt and more precise commentary on maintenance and labor costs that have kept per-unit economics elevated.

For sector peers, CMP’s quarterly drumbeat reinforces a familiar tension: price discipline and operational discipline in Plant Nutrition versus the cost-driven volatility of Salt and its distribution network. The Street will be scanning not only EPS consensus revisions but also the degree to which management can convert quarterly EBITDA momentum into a durable, free-cash-flow-friendly trajectory.

Notes from the executive suite

“What we are experiencing in our Plant Nutrition business is the clearest example of what our improvement process can deliver. We produced segment Adjusted EBITDA of $15.0 million in the quarter on improved pricing and lower per-unit costs, and we have again raised our full-year expectations for this business. In Salt, we realized meaningful pricing gains in highway during the quarter, and we are seeing early signs of a constructive pricing environment within our consumer and industrial (C&I) product line as well. However, production costs at our mining operations have not yet improved at the pace we expected. Production tons are up year over year, but as we invest in maintenance, labor and associated costs have remained elevated relative to plan. We raised our full-year consolidated Adjusted EBITDA guidance midpoint to $230 million, driven by significantly stronger Plant Nutrition performance partially offset by mix, inflationary pressures and the pace of operational improvements in Salt.”

Tickers, numbers, and the long arc

CMP remains the ticker to watch for investors seeking exposure to essential minerals with a dual-acting engine: a growth-oriented Plant Nutrition segment and a Salt operation sensitive to weather, pricing, and distribution costs. The near-term ledger shows a narrowed net loss, an EBITDA cadence that beats or matches expectations in pockets, and a balance sheet that is gradually thinning its interest expenses and leverage.